Found 18 matching trials
MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML) PHASE1 This is a dose-escalation phase I trial to evaluate the safety and tolerabi...
Show More Location
St Vincent's Hospital Sydney Limited
Learn More & Join Trial
National Registry of Rare Kidney Diseases N/A The goal of this National Registry is to is to collect information from pat...
Show More Learn More & Join Trial
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation PHASE2 In this trial, we aim to improve the outcomes of haplo cord transplant. Hap...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation N/A To achieve optimal long-term clinical results after percutaneous coronary i...
Show More Location
Catharina Hospital
Learn More & Join Trial
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases PHASE1 In this phase 1 open label study for patients with type I punctate palmopla...
Show More Location
Soroka Medical Center
Learn More & Join Trial
Assessment of a Wearable Ultrafiltration Device NA Kidney failure is common. In some people the ability of the kidneys to clea...
Show More Location
London Health Sciences Centre
Learn More & Join Trial
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes PHASE2 The purpose of this study is to evaluate the efficacy, safety, and pharmaco...
Show More Location
Institute of Hematology and Blood Diseases Hospital
Learn More & Join Trial
Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) PHASE1 The purpose of this study is to see the effects of an investigational combi...
Show More Location
University of Miami
Learn More & Join Trial
Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC PHASE1 This Phase 1b, open-label, single-center, prospective trial will be assessi...
Show More Location
Royal London Hospital-Clinical Research Facility-11D (11th Floor) Whitechapel, London, E1 1FR,
Learn More & Join Trial
PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) NA This study is a prospective Phase I/II protocol enrolling men with either h...
Show More Status
Active Not Recruiting
Location
London Health Sciences Centre
Learn More & Join Trial